( He ( ( stressed ( that ( ( ( the majority ) ( of ( nevirapine-associated rashes ) ) ) ( occur ( within ( ( the ( first ( 6-8 weeks ) ) ) ( of ( starting ( therapy ( -LRB- ( ( Figure 8 ) -RRB- ) ) ) ) ) ) ) ) ) ) ) . ) )
(ROOT (S (NP (PRP He)) (VP (VBD stressed) (SBAR (IN that) (S (NP (NP (DT the) (NN majority)) (PP (IN of) (NP (JJ nevirapine-associated) (NNS rashes)))) (VP (VBP occur) (PP (IN within) (NP (NP (DT the) (JJ first) (CD 6-8) (NNS weeks)) (PP (IN of) (S (VP (VBG starting) (NP (NP (NN therapy)) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 8)) (-RRB- -RRB-)))))))))))) (. .)))
He stressed that the majority of nevirapine-associated  rashes occur within the first 6-8 weeks of starting therapy ( Figure 8 ).
(ROOT (S (PP (IN By) (NP (CD 8) (NNS weeks))) (, ,) (NP (DT all) (JJ major) (NNS organs)) (VP (VBP start) (S (VP (VBG developing)))) (. .)))